Retatrutide | 30mg / 2mL

Merlyn's Retatrutide 30 mg is a high-purity synthetic tri-agonist peptide, 
engineered with advanced wet inclusion technology inspired by immunoglobulin 
stabilization methods. This formulation incorporates the peptide into a hydrated matrix 
using HPBCD (hydroxypropyl-beta-cyclodextrin) as a stabilizer, along with conjugated 
fragments that enhance structural integrity. Similar to enhanced IgG products, it 
features whole-molecule stability, conjugated segments for deeper tissue penetration, 
and peptide fragments that may support prolonged activity in research models. Ideal 
for metabolic studies targeting GLP-1, GIP, and glucagon receptors.
Key Benefits:
• Greater stability during storage, shipment, light, and temperature changes due 
to HPBCD complexation, reducing degradation.
• Prolonged effectiveness through extended half-life of conjugated fragments (up 
to 20 times longer than standard), allowing for sustained release in aqueous 
environments.
• Potential to explore enhanced efficacy in glucose regulation, appetite control, 
and energy metabolism research via self-assembling hydrogel-like structures.
• Biocompatible design that facilitates controlled diffusion and deeper model 
penetration, mimicking active inclusion bodies for functional protein recovery.
Important Notes: For research use only.